Helicobacter pylori infection generates genetic instability in gastric cells

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1806, Issue 1, 2010, Pages 58-65

  Machado, Ana Manuel Dantas ^a,b   Figueiredo, Céu ^b,c   Seruca, Raquel ^b   Rasmussen, Lene Juel ^d  

^a ROSKILDE UNIVERSITY   (Denmark)

^b UNIVERSITY OF PORTO   (Portugal)

^c Faculty of Engineering of Porto   (Portugal)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

DNA repair; Gastric cancer; Genetic instability; H. pylori

Indexed keywords

CAGA PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MISMATCH REPAIR PROTEIN PMS2; MITOCHONDRIAL DNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UVOMORULIN;

APOPTOSIS; BACTERIAL COLONIZATION; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; CHRONIC GASTRITIS; CPG ISLAND; DNA DAMAGE; EXCISION REPAIR; GENE MUTATION; GENOMIC INSTABILITY; HELICOBACTER INFECTION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INFECTION; INFLAMMATION; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MITOCHONDRIAL GENOME; NONHUMAN; OXIDATIVE STRESS; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EROSION; STOMACH ULCER;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; DNA, MITOCHONDRIAL; GENOMIC INSTABILITY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 77953718630     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2010.01.007     Document Type: Review

References (183)

1. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999, 284:1328-1333.
2. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.
3. Schistosomes, liver flukes and Helicobacter pylori: IARC working group on the evaluation of carcinogenic risks to humans, IARC monographs on the evaluation of carcinogenic risks to humans, IARC Scientific Publications no. 61, Lyon, France, 1994, pp.218-220.
4. Sipponen P., Marshall B.J. Gastritis and gastric cancer. Western countries. Gastroenterol. Clin. N. Am. 2000, 29:579-592.
5. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992, 52:6735-6740.
6. Peterson W.L. Helicobacter pylori and peptic ulcer disease. N. Engl. J. Med. 1991, 324:1043-1048.
7. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988, 48:3554-3560.
8. Dixon M.F. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001, 49:2-4.
9. El-Omar E.M. The importance of interleukin 1 beta in Helicobacter pylori associated disease. Gut 2001, 48:743-747.
10. El-Omar E.M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., Wiliams C., Ardill J.E., McColl K.E. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997, 113:15-24.
11. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature 2002, 2:28-37.
12. Correa P. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol. Biomarkers Prev. 1996, 5:477-481.
13. Figueiredo C., Machado J.C., Pharaoh P., Seruca R., Sousa S., Carvalho R., Capelinha A.F., Quint W., Caldas C., van Doorn L.J., Carneiro F., Sobrinho-Simões M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 2002, 94:1680-1687.
14. Machado J.C., Pharoah P., Sousa S., Carvalho R., Oliveira C., Figueiredo C., Amorim A., Seruca R., Caldas C., Carneiro F., Sobrinho-Simões M. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001, 121:823-829.
15. Machado J.C., Figueiredo C., Canedo P., Pharoah P., Carvalho R., Nabais S., Castro-Alves C., Campos M.L., van Doorn L.J., Caldas C., Seruca R., Carneiro F., Sobrinho-Simões M. A proinflammatoty genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003, 125:364-371.
16. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., Stemmermann G.N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995, 55:2111-2115.
17. Odenbreit S., Puls J., Sedlmaier B., Gerland E., Fischer W., Haas R. Translocation of Helicobacter pylori cagA into gastric epithelial cells by type IV secretion system. Science 2000, 287:1497-1500.
18. Segal E.D., Cha J., Lo J., Falkow S., Tompkins L.S. Altered states: involvement of phosphorylated cagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14559-14564.
19. Churin Y., Al-Ghoul L., Kepp O., Meyer T.F., Birchmeiee W., Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol. 2003, 161:249-255.
20. Oliveira M.J., Costa A.C., Costa A.M., Henriques L., Suriano G., Atherton J.C., Machado J.C., Carneiro F., Seruca R., Mareel M., Leroy A., Figueiredo C. Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner. J. Biol. Chem. 2006, 281:34888-34896.
21. Amieva M.R., Vogelmann R., Covacci A., Tompkins L.S., Nelson W.J., Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003, 300:1430-1434.
22. Backert S., Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol. 2008, 10:1573-1581.
23. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., Ohno S., Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007, 447:330-333.
24. Cover T.L., Blaser M.J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 1992, 267:10570-10575.
25. Cover T.L., Blanke S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 2005, 3:320-332.
26. Rudi J., Kuck D., Strand S., von Herbay A., Mariani S.M., Krammer P.H., Galle P.R., Stremmel W. Involvement of the CD95 [APO-1/Fas] receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J. Clin. Invest. 1998, 102:1506-1514.
27. Peek R.M., Blaser M.J., Mays D.J., Forsyth M.H., Cover T.L., Song S.Y., Krishna U., Pietenpol J.A. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res. 1999, 59:6124-6131.
28. Galmiche A., Rassow J., Doye A., Cagnol S., Chambard J.C., Contamin S., de Thillot V., Just I., Ricci V., Solcia E., van Obberghen E., Boquet P. The N-terminal 34kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J. 2000, 19:6361-6370.
29. Kuck D., Kolmerer B., Iking-Konert C., Krammer P.H., Stremmel W., Rudi J. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect. Immun. 2001, 69:5080-5087.
30. Atherton J.C., Cao P., Peek R.M., Tummuru K.R.M.K.R., Blaser M.J., Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 1995, 270:17771-17777.
31. Atherton J.C., Peek R.M., Tham K.T., Cover T.L., Blaser M.J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenteroloy 1997, 112:92-99.
32. L.J. van Doorn, C. Figueiredo, R. Sanna, S. Pena, P. Midolo, E.K.W. Ng, J.C. Atherton, M.J. Blaser, W.G.V. Quint, Expanding allelic diversity of Helicobacter pylori vacA, J. Clin. Microbiol. 36 (1998) 2597-2603, Erratum in: J. Clin. Microbiol. 38 (2000) 2464.
33. Rhead J.L., Letley D.P., Mohammadi M., Hussein N., Mohagheghi M.A., Eshagh Hosseini M., Atherton J.C. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007, 133:926-936.
34. van Doorn L.J., Figueiredo C., Sanna R., Plaisier A., Schneeberger P., de Boer W., Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998, 115:58-66.
35. Nogueira C., Figueiredo C., Carneiro F., Gomes A.T., Barreira R., Figueira P., Salgado C., Belo L., Peixoto A., Bravo J.C., Bravo L.E., Realpe J.L., Plaisier A.P., Quint W.G.V., Ruiz B., Correa P., van Doorn L.J. Helicobacter pylori genotypes may determine gastric histopathology. Am. J. Pathol. 2001, 158:647-654.
36. Basso D., Zambon C.F., Letley D.P., Stranges A., Marchet A., Rhead J.L., Schiavon S., Guariso G., Ceroti M., Nitti D., Rugge M., Plebani M., Atherton J.C. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008, 135:91-99.
37. Peek R.M. Microbes and microbial toxins: paradigms for microbial-mucosal interaction. IV. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G525-G530.
38. Crabtree J.E., Wyatt J.I., Trjdosiewicz L.K., Peichl P., Nichols H., Ramsay N., Primrose J.N., Lindley I.J. Interleukin-8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J. Clin. Pathol. 1995, 47:61-66.
39. + Helicobacter pylori strains. Lab. Invest. 1995, 73:760-770.
40. Romano M., Ricci V., Memoli A., Tuccillo C., Di Popolo A., SOmmi P., Acquaviva A.M., del Vecchio Blanco C. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J. Biol. Chem. 1998, 273:28560-28563.
41. Sawaocka H., Kawano S., Tsuji S., Tsuji M., Sun W., Gunawan E.S., Hori M. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot. Essent. Fatty Acids 1998, 59:313-316.
42. Fu S., Ramanujam K.S., Wong A., Fantry G.T., Drachenberg C.B., James S.P., Meltzer S.J., Wilson K.T. Increased expression and cellular localization of inducible nitric oxide synthesis and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999, 116:1319-1329.
43. Perez-Perez G.I., Garza-Gonzalez E., Portal C., Olivares A.Z. Role of cytokine polymorphisms in the risk of distal gastric cancer development. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1869-1873.
44. E.M. El-Omar, M. Carrington, W.H. Chow, K.E. McColl, J.H. Bream, H.A. Young, J. Herrera, J. Lissowska, C.C. Yuan, N. Rothman, G. Lanyon, M. Martin, J.F. Fraumeni Jr., C.S. Rabkin, Interleukin-1 polymorphisms associated with increased risk of gastric cancer, Nature 404 (2000) 398-402. Erratum in: Nature 412 (2001) 99.
45. Furuta T., Shirai N., Sugimoto M. Controversy in polymorphisms of interleukin-1beta in gastric cancer risks. J. Gastronterol. 2004, 39:501-503.
46. Palli D., Saieva C., Luzzi I., Masala G., Topa S., Sera F., Gemma S., Zanna I., D'Errico M., Zini E., Guidotti S., Valeri A., Fabbrucci P., Moretti R., Testai E., Del Giudice G., Ottini L., Matullo G., Dogliotti E., Gomez-Miguel M.J. Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population. Am. J. Gastronterol. 2005, 100:1941-1948.
47. El-Omar E.M., Rabkin C.S., Gammon M.D., Vaughan T.L., Risch H.A., Schoenberg J.B., Stanford J.L., Mayne S.T., Goedert J., Blot W.J., Fraumeni J.F., Chow W.H. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193-1201.
48. Lee W.P., Tai D.I., Lan K.H., Li A.F., Hsu H.C., Lin E.J., Lin Y.P., Sheu M.L., Li C.P., Chang F.Y., Chao Y., Yen S.H., Lee S.D. The-251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin. Cancer Res. 2005, 11:6431-6441.
49. Taguchi A., Ohmiya N., Shirai K., Mabuchi N., Itoh A., Hirooka Y., Niwa Y., Goto H. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2487-2493.
50. Canedo P., Castanheira-Vale A.J., Lunet N., Pereira F., Figueiredo C., Gioia-Patricola L., Canzian F., Moreira H., Suriano G., Barros H., Carneiro F., Seruca R., Machado J.C. The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur. J. Cancer Prev. 2008, 17:28-32.
51. Xia H.H.X., Talley N.J. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am. J. Gastroenterol. 2001, 96:16-26.
52. Moss S.F., Calam J., Agarwal B., Wang S., Holt P.R. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996, 38:498-501.
53. Mannick E.E., Bravo L.E., Zarama G., Realpe J.L., Zhang X.J., Ruiz B., Fontham E.T., Mera R., Miller M.J., Correa P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 1996, 56:3238-3243.
54. Jones N.L., Shannon P.T., Cutz E., Yeger H., Sherman P.M. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am. J. Pathol. 1997, 151:1695-1703.
55. + Helicobacter pylori strains. Cancer Res. 2001, 61:1406-1411.
56. Anti M., Armuzzi A., Iascone E., Valenti A., Lippi M.E., Covino M., Vecchio F.M., Pierconti F., Buzzi A., Pignataro G., Bonvicini F., Gasbarrini G. Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital. J. Gastroenterol. Hepatol. 1998, 30:153-159.
57. Hirasawa R., Tatsuta M., Iishi H., Yano H., Baba M., Uedo N., Sakai N. Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori. Am. J. Gastroenterol. 1999, 94:2398-2402.
58. Wagner S., Beil W., Westermann J., Logan R.P., Bock C.T., Trautwein C., Bleck J.S., Manns M.P. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 1997, 113:1836-1847.
59. Chen G., Sordillo E.M., Ramey W.G., Reidy J., Holt P.R., Krajewski S., Reed J.C., Blaser M.J., Moss S.F. Apoptosis in gastric epithelial cells is induced by Helicobacter pylori and accompanied by increased expression of Bak. Biochem. Biophys. Res. Commun. 1997, 239:626-632.
60. Fan X., Crowe S.E., Behar S., Gunasena H., Ye G., Haeberle H., van Houten N., Gourley W.K., Ernst P.B., Reyes V.E. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med. 1998, 187:1659-1669.
61. Houghton J., Korah R.M., Condon M.R., Kim K.H. Apoptosis in Helicobacter pylori-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway. Dig. Dis. Sci. 1999, 44:465-478.
62. Jones N.L., Day A.S., Jennings H.A., Sherman P.M. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 1999, 67:4237-4242.
63. Bhattacharyya A., Chattopadhyay R., Burnette B.R., Cross J.V., Mitra S., Ernst P.B., Bhakat K.K., Crowe S.E. Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology 2009, 136:2258-2269.
64. Moss S.F. Cellular markers in the gastric precancerous process. Aliment. Pharmacol. Ther. 1998, 12:91-109.
65. Yamasaki E., Wada A., Kumatori A., Nakagawa I., Funao J., Nakayama M., Hisatsune J., Kimura M., Moss J., Hirayama T. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J. Biol. Chem. 2006, 281:11250-11259.
66. Correa P., Ruiz B., Shi T.Y., Janney A., Sobhan M., Torrado J., Hunter F. Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am. J. Clin. Pathol. 1994, 101:656-660.
67. Fraser A.G., Sim R., Sankey E.A., Dhillon A.P., Pounder R.E. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment. Pharmacol. Ther. 1994, 8:167-173.
68. Lynch D.A., Clarke A.M., Jackson O., Axon A.T., Dixon M.F., Quirke P. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995, 36:346-350.
69. Cahill R.J., Xia H., Kilgallen C., Beattie S., Hamilton H., O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig. Dis. Sci. 1995, 40:1627-1631.
70. Havard T.J., Sarsfield P., Wotherspoon A.C., Steer H.W. Increased gastric epithelial cell proliferation in Helicobacter pylori associated follicular gastritis. J. Clin. Pathol. 1996, 49:68-71.
71. + strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl. Cancer Inst. 1997, 89:863-868.
72. Brenes F., Ruiz B., Correa P., Hunter F., Rhamakrishnan T., Jonathan E., Shi T.Y. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am. J. Gastroenterol. 1993, 88:1870-1875.
73. Hibi K., Mitomi H., Koizumi W., Tanable S., Saigenji K., Okayasu I. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am. J. Clin. Pathol. 1997, 108:26-34.
74. Lynch D.A.F., Mapstone N.P., Clarke A.M.T., Jackson P., Moayyedi P., Dixon M.F., Quirke P., Axon A.T.R. Correlation between epithelial cell proliferation and histological grading in gastric mucosa. J. Clin. Pathol. 1999, 52:367-371.
75. Fox J.G., Dangler C.A., Taylor N.S., King A., Koh T.J., Wang T.C. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res. 1999, 59:4823-4828.
76. Peek R.M., Wirth H.P., Moss S.F., Yang M., Abdalla A.M., Tham K.T., Zhang T., Tang L.H., Modlin I.M., Blaser M.J. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 2000, 118:48-59.
77. Israel D.A., Salama N., Arnold C.N., Moss S.F., Ando T., Wirth H.P., Tham K.T., Camorlinga M., Blaser M.J., Falkow S., Peek R.M. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Invest. 2001, 107:611-620.
78. Shirin H., Sordillo E.M., Oh S.H., Yamamoto H., Delohery T., Weinstein I.B., Moss S.F. Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells. Cancer Res. 1999, 59:2277-2281.
79. Ahmed A., Smoot D., Littleton G., Tackey R., Walters C.S., Kashanchi F., Allen C.R., Ashktorab H. Helicobacter pylori inhibits gastric cell cycle progression. Microbes Infect. 2000, 2:1159-1169.
80. Kohda K., Tanaka K., Aiba Y., Yasuda M., Miwa T., Koga Y. Role of apoptosis induced by Helicobacter pylori infection in the development of duodenal cancer. Gut 1999, 44:456-462.
81. Leung W.K., To K.F., Chan F.K., Lee T.L., Chung S.C., Sung J.J. Interaction of Helicobacter pylori eradication and non-steroidal anti-inflammatory drugs on gastric epithelial apoptosis and proliferation: implications on ulcerogenesis. Aliment. Pharmacol. Ther. 2000, 14:879-885.
82. Yoshimura T., Shimoyama T., Tanaka M., Sasaki Y., Fukuda S., Munakata A. Gastric mucosal inflammation and epithelial turnover are associated with gastric cancer in patients with Helicobacter pylori infection. J. Clin. Pathol. 2000, 53:532-536.
83. Satunton M.U., Gaffney E.F. Apoptosis. Basic concepts and potential significance in human cancer. Arch. Pathol. Lab. Med. 1998, 122:310-319.
84. Cervantes A., Braun E.R., Fidalgo A.P., González I.C. Molecular biology of gastric cancer. Clin. Transl. Oncol. 2007, 9:208-215.
85. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349:2042-2054.
86. Tamura G., Yin J., Wang S., Fleisher A.S., Zou T., Abraham J.M., Kong D., Smolinski K.N., Wilson K.T., James S.P., Silverberg S.G., Nishizuka S., Terashima M., Motoyama T., Meltzer S.J. E-cadherin gene promoter hypermethylation in primary human gastric carcinoma. J. Natl. Cancer Inst. 2000, 92:569-573.
87. Carvalho B., Pinto M., Cirnes L., Oliveira C., Machado J.C., Suriano G., Hamelin R., Carneiro F., Seruca R. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur. J. Cancer 2003, 39:1222-1227.
88. Leung S.Y., Yuen S.T., Chung L.P., Chu K.M., Chan A.S.Y., Ho J.C.I. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 1999, 59:159-164.
89. Endoh H., Tamura G., Ajioka Y., Watanabe H., Motoyama T. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumor of the stomach with the gastric foveolar phenotype. Am. J. Pathol. 2000, 157:717-722.
90. Pinto M., Oliveira C., Machado J.C., Cirnes L., Tavares J., Carneiro F., Hamelin R., Hofstra R., Seruca R., Sobrinho-Simões M. MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile. Lab. Invest. 2000, 80:1915-1923.
91. Semba S., Yokozaki H., Yamamoto S., Yasui W., Tahara E. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 1996, 77:1620-1627.
92. Ottini L., Palli D., Falchetti M., D'Amico C., Amorosi A., Saieva C., Calzolari A., Cimoli F., Tatarelli C., De Marchis L., Masala G., Mariani-Costantini R., Cama A. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high risk population from Tuscany. Cancer Res. 1997, 57:4523-4529.
93. Oliveira C., Seruca R., Seixas M., Sobrinho-Simões M. The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFβ RII, IGFII, and BAX genes. Am. J. Pathol. 1998, 153:1211-1219.
94. Velho S., Oliveira C., Ferreira A., Ferreira A.C., Suriano G., Schwartz S., Duval A., Carneiro F., Machado J.C., Hamelin R., Seruca R. The prevalence of PIK3CA mutations in gastric and colon cancer. Eur. J. Cancer 2005, 41:1649-1654.
95. Rhyu M.G., Park W.S., Yung Y.J., Choi S.W., Meltzer S.J. Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 1994, 106:1584-1588.
96. Wu M.S., Shun C.T., Wang H.P., Sheu J.C., Lee W.J., Wang T.H., Lin J.T. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage and Helicobacter pylori infection. Gastroenterology 1997, 112:1457-1465.
97. Brito M.J., Williams G.T., Thompson H., Filipe M.I. Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa. Gut 1994, 35:1697-1700.
98. Graziano F., Cascinu S., Staccioli M.P., Catalano V., Rossi M.C., Baldelli A.M., Giordani P., Muretto P., Catalano G. Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and p53 proteins in the development of gastric cancer. B.M.C. Cancer 2001, 1:9.
99. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Kato Y., Yanagisawa A., Nakamura Y. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res. 1992, 52:3231-3233.
100. Hsieh L.L., Huang Y.C. Loss of heterozygosity of APC/MCC gene in differentiated and undifferentiated gastric carcinomas in Taiwan. Cancer Lett. 1995, 96:169-174.
101. Fang D.C., Jass J.R., Wang D.X. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J. Clin. Pathol. 1998, 51:593-596.
102. Baffa R., Veronese M.L., Santoro R., Mandes B., Palazzo J.P., Rugge M., Santoro E., Croce C.M., Huebner K. Loss of FHIT expression in gastric carcinoma. Cancer Res. 1998, 58:4708-4714.
103. Capuzzi D., Santoro E., Hauck W.W., Kovatich A.J., Rosato F.E., Baffa R., Huebner K., McCue P.A. FHIT expression in gastric adenocarcinoma: correlation with disease stage and survival. Cancer 2000, 88:24-34.
104. Huiping C., Kristjandottir S., Bergthorson J.T., Jonasson J.G., Magnusson J., Egilsson V., Ingvarsson S. High frequency of LOH, MSI, and abnormal expression of FHIT in gastric cancer. Eur. J. Cancer 2002, 38:728-735.
105. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.C., Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
106. Tamura G., Nishizuka S., Maesawa C., Suzuki Y., Iwaya T., Sakata K., Endoh Y., Motoyama T. Mutations in mitochondrial control region DNA in gastric tumors of Japanese patients. Eur. J. Cancer 1999, 35:316-319.
107. Habano W., Sugai T., Nakamura S.I., Uesugi N., Yoshida T., Sasou S. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology 2000, 118:835-841.
108. Máximo V., Soares P., Seruca R., Rocha A.S., Castro P., Sobrinho-Simões M. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes, Chromosomes Cancer 2001, 32:136-143.
109. Wu C.W., Yin P.H., Hung W.Y., Li A.F., Li S.H., Chi C.W., Wei Y.H., Lee H.C. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes, Chromosomes Cancer 2005, 44:19-28.
110. Phe and gastric carcinomas. World J. Gastroenterol. 2003, 9:1925-1929.
111. Palombo F., Gallinari P., Iaccarino I., Lettieri T., Hughes M., D'Arrigo A., Truong O., Hsuan J.J., Jiricny J. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995, 268:1912-1914.
112. Palombo F., Iaccarino I., Nakajima E., Ikejima M., Shimada T., Jiricny J. hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol. 1996, 6:1181-1184.
113. Li G.M., Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1950-1954.
114. Räschle M., Marra G., Nystrom-Lahti M., Schär P., Jiricny J. Identification of hMutLβ, a heterodimer of hMLH1 and hPMS1. J. Biol. Chem. 1999, 274:32368-32375.
115. Li G.M. DNA mismatch repair and cancer. Front. Biosci. 2003, 8:997-1017.
116. Kim J.J., Tao H., Carloni E., Leung W.K., Graham D.Y., Sepulveda A.R. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 2002, 123:542-553.
117. Park D.I.I., Park S.H., Kim S.H., Kim J.W., Cho Y.K., Kim H.J., Sohn C.I., Jeon W.K., Kim B.I., Cho E.Y., Kim E.J., Chae S.W., Sohn J.H., Sung I.K., Sepulveda A.R., Kim J.J. Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein. Helicobacter 2005, 10:179-184.
118. Mirzaee V., Molaei M., Shalmani H.M., Zali M.R. Helicobacter pylori infection and expression of DNA mismatch repair proteins. World J. Gastroenterol. 2008, 14:6717-6721.
119. Machado A.M.D., Figueiredo C., Touati E., Máximo V., Sousa S., Michel V., Carneiro F., Nielsen F.C., Seruca R., Rasmussen L.J. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin. Cancer Res. 2009, 15:2995-3002.
120. Barnes D.E., Lindahl T., Sedgwick B. DNA repair. Curr. Opin. Cell Biol. 1993, 5:424-433.
121. Loeb L.A., Preston B.D. Mutagenesis by aputinic/apyrimidinic sites. Annu. Rev. Genet. 1986, 20:201-230.
122. Gentil A., Cabral-Neto J.B., Sarasin A. Mutagenicity of a unique apurinic/apyrimidinic site in mammalian cells. J. Mol. Biol. 1992, 227:981-984.
123. Guillet M., Boiteux S. Endogenous DNA abasic sites cause cell death in the absence of Apn1, Apn2 and Rad1/Rad10 in Saccharomyces cerevisiae. EMBO J. 2002, 21:2833-2841.
124. Fortini P., Pascucci B., Parlanti E., D'Errico M., Dogliotti E. The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie 2003, 85:1053-1071.
125. Glassner B.J., Rasmussen L.J., Najarian M.T., Posnick L.M., Samson L.D. Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9997-10002.
126. 2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 2004, 127:845-858.
127. Futagami S., Hiratsuka T., Shindo T., Horie A., Hamamoto T., Suzuki K., Kusunoki M., Miyake K., Gudis K., Crowe S.E., Tsukui T., Sakamoto C. Expression of apurinic/apyrimidinic endonuclease-1 (APE-1) in H. pylori-associated gastritis, gastric adenoma, and gastric cancer. Helicobacter 2008, 13:209-218.
128. Meira L.B., Bugni J.M., Green S.L., Lee C.W., Pang B., Borenshtein D., Rickman B.H., Rogers A.B., Moroski-Erkul C.A., McFaline J.L., Schauer D.B., Dedon P.C., Fox J.G., Samson L.D. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 2008, 118:2516-2525.
129. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
130. De Bont R., van Larabeke N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 2004, 19:169-185.
131. Bartsch H. Keynote address: exocyclic adducts as new risk markers for DNA damage in man. IARC Sci. Publ. 1999, 150:1-16.
132. Smoot D.T., Elliot T.B., Verspaget H.W., Jones D., Allen C.R., Vernon K.G., Bremner T., Kidd L.C.R., Kim K.S., Groupman J.D., Ashktorab H. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis 2000, 21:2091-2095.
133. Izzotti A., De Flora S., Cartiglia C., Are B.M., Longobardi M., Camoirano A., Mura I., Dore M.P., Scanu A.M., Rocca P.C., Maida A., Piana A. Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa. Carcinogenesis 2007, 28:892-898.
134. Obst B., Wagner S., Sewing K.F., Beil W. Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 2000, 21:1111-1115.
135. Bagchi D., Bhattacharya G., Stos S.J. Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic. Res. 1996, 24:439-450.
136. Bagchi D., McGinn T.R., Ye X., Bagchi M., Krohn R.L., Chatterjee A., Stohs S.J. Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells. Dig. Dis. Sci. 2002, 47:1405-1412.
137. Khanzode S.S., Khanzode S.D., Dakhale G.N. Serum and plasma concentration of oxidant and antioxidants in patients of Helicobacter pylori gastritis and its correlation with gastric cancer. Cancer Lett. 2003, 195:27-31.
138. Yao Y., Tao H., Park D.I., Sepúlveda J.L., Sepúlveda A.R. Demonstration and characterization of mutations induced by Helicobacter pylori organisms in gastric epithelial cells. Helicobacter 2006, 11:272-286.
139. Perri F., Cotugno R., Piepoli A., Merla A., Quitadamo M., Gentile A., Pilotto A., Annese V., Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am. J. Gastroenterol. 2007, 102:1361-1371.
140. Chan A.O.O., Lam S.K., Wong B.C.Y., Wong W.M., Yuen M.F., Yeung Y.H., Hui W.M., Rashid A., Kwong Y.L. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003, 52:502-506.
141. Dong C.X., Deng D.J., Pan K.F., Zhang L., Zhang Y., Zhou J., You W.C. W.C., Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int. J. Cancer 2009, 124:434-439.
142. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., Tamura G., Saito D., Sugimura T., Ichinose M., Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori infected mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 2006, 12:989-995.
143. Chan A.O., Peng J.Z., Lam S.K., Lai K.C., Yuen M.F., Cheung H.K.L., Kwong Y.L., Rashid A., Chan C.K., Wong B.C.Y. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006, 55:463-468.
144. Leung W.K., Man E.P., Yu J., Go M.Y.Y., To K.F., Yamaoka Y., Cheng V.Y.Y., Ng E.K.W., Sung J.J.Y. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin. Cancer Res. 2006, 12:3216-3221.
145. Holliday R., Ho T. Gene silencing and endogenous DNA methylation in mammalian cells. Mutat. Res. 1998, 400:361-368.
146. Stern L.L., Mason J.B., Selhub J., Choi SW S.W. Genomics DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphis in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomarkers Prev. 2000, 9:849-853.
147. Barbarella G., Tugnoli V., Zambianchi M. Imidazole ring opening of 7-methylguanosine at physiologic pH. Nucleosides Nucleotides Nucleic Acids 1991, 10:1759-1769.
148. Tudek B., Boiteux S., Laval J. Biological properties of imidazole ring opened N7-methylguanine in M13mp18 phage DNA. Nucleic Acids 1992, 20:3079-3084.
149. Umeda M., Murata-Kamiya N., Saito Y., Ohba Y., Takahashi M., Hatakeyama M. Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability. J. Biol. Chem. 2009, 284:22166-22172.
150. Touati E., Michel V., Thiberge J.M., Wuscher N., Huerre M., Labigne A. Chronic Helicobacter pylori infections induces gastric mutations in mice. Gastroenterology 2003, 124:1408-1419.
151. Hiyama T., Tanaka S., Shima H., Kose K., Kitadai Y., Ito M., Sumii M., Yoshihara M., Shimamoto F., Haruma K., Chayama K. Somatic mutation of mitochondrial DNA in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int. J. Mol. Med. 2003, 12:169-174.
152. Lee S., Shin M.G., Jo W.H., Kim M.J., Kim H.R., Park D.H., Won J.H., Shin J.H., Suh S.P., Ryang D.W. Association between Helicobacter pylori-related peptic ulcer tissue and somatic mitochondrial DNA mutations. Clin. Chem. 2007, 53:1390-1392.
153. Chatterjee A., Mambo E., Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 2006, 25:4663-4674.
154. Baik S.C., Youn H.S., Chung M.H., Lee W.K., Cho M.J., Ko G.H. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 1996, 56:1279-1282.
155. Arabski M., Klupinska G., Chojnacki J., Kazmierczak P., Wisniewska-Jarosinska M., Drzewoski J., Blasiak J. DNA damage and repair in Helicobacter pylori-infected gastric mucosa cells. Mutat. Res. 2005, 570:129-135.
156. Davies G.R., Simmonds N.J., Stevens T.R.J., Sheaff M.T., Banatvala N., Laurenson I.F., Blake D.R., Rampton D.S. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994, 35:179-185.
157. Davies G.R., Banatvala N., Collins C.E., Sheaff M.T., Abdi Y., Clements L., Rampton D.S. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand. J. Gastroenterol. 1994, 29:419-424.
158. Zhang Q., Dawodu J.B., Etolhi G., Husain A., Gemmel C.G., Russel R.I. Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer. Eur. J. Gastroenterol. Hepatol. 1997, 9:261-265.
159. Ladeira M.S.P., Rodrigues M.A.M., Salvadori D.M.F., Queiroz D.M.M., Freire-Maia D.V. DNA damage in patients infected by Helicobacter pylori. Cancer Epidemiol. Biomarkers Prev. 2004, 13:631-637.
160. Siomek A., Rytarowska A., Szaflarska-Poplawska A., Gackowski D., Rozalski R., Dziaman T., Czerwionka-Szaflarska M., Olinski R. Helicobacter pylori infection is associated with oxidatively damaged DNA inhuman leukocytes and decreased level of urinary 8-oxo-7, 8-dihydroguanine. Carcinogenesis 2006, 27:405-408.
161. Gobbo Cesar A.C., de Freitas Calmon M., Cury P.M., Caetano A., Borim A.A., Silva A.E. Genetic alterations in benign lesions: chronic gastritis and gastric ulcer. World J. Gastroenterol. 2006, 12:625-629.
162. Nardone G., Staibano S., Rocco A., Mezza E., D'Armiento F.P., Insabato L., Coppola A., Salvatore G., Lucariello A., Figura N., De Rosa G., Budillon G. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999, 44:789-799.
163. Shibata A., Parsonnet J., Longacre T.A., Garcia M.I., Pulogandla B., Davis R.E. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis 2002, 23:419-424.
164. Kodama M., Murakami K., Okimoto T., Sato R., Watanabe K., Fujioka T. Expression of mutant type-p53 products in H. pylori-associated chronic gastritis. World J. Gastroenterol. 2007, 13:1541-1546.
165. Li J.H., Shi X.Z., Lv S., Liu M., Xu G.W. Effect of Helicobacter pylori infection on p53 expression of gastric mucosa and adenocarcinoma with microsatellite instability. World J. Gastroenterol. 2005, 11:4363-4366.
166. Teh M., Tan K.B., Seet B.L., Yeoh K.G. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis. Cancer 2002, 95:499-505.
167. Kodama M., Fujioka T., Murakami K., Okimoto T., Sato R., Watanabe K., Nasu M. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa. J. Gastroenterol. Hepatol. 2005, 20:941-946.
168. Satoh K., Kihira K., Kawata H., Tokumaru K., Kumakura Y., Ishino Y. p53 expression in the gastric mucosa before and after eradication of Helicobacter pylori. Helicobacter 2001, 6:31-36.
169. Sawyer D.E., van Houten B. Repair of DNA damage in mitochondria. Mutat. Res. 1999, 434:161-176.
170. Bogenhagen D.F., Pinz K.G., Perez-Jannotti R.M. Enzymology of mitochondrial base excision repair. Prog. Nucl. Acid Res. Mol. Biol. 2001, 68:257-271.
171. Dianov G.L., Souza-Pinto N., Nyaga S.G., Thybo T., Stevnsner T., Bohr V.A. Base excision repair in nuclear and mitochondrial DNA. Prog. Nucl. Acid Res. Mol. Biol. 2001, 68:285-297.
172. LeDoux S.P., Wilson G.L. Base excision repair of mitochondrial DNA damage in mammalian cells. Prog. Nucl. Acid Res. Mol. Biol. 2001, 68:273-284.
173. Bohr V.A. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic. Biol. Med. 2002, 32:804-812.
174. Nishioka K., Ohtsubo T., Oda H., Fujiwara T., Kang D., Sugimachi K., Nakabeppu Y. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol. Biol. Cell 1999, 10:1637-1652.
175. Takao M., Aburatani H., Kobayashi K., Yasui A. Mitochondrial targeting of human DNA glycosylases for repair of oxidative DNA damage. Nucl. Acids Res. 1998, 26:2917-2922.
176. Parker A., Gu Y., Lu A.L. Purification and characterization of a mammalian homolog of Escherichia coli MutY mismatch repair protein from calf liver mitochondria. Nucl. Acids Res. 2000, 28:3206-3215.
177. Stierum R.H., Croteau D.L., Bohr V.A. Purification and characterization of a mitochondrial thymine glycol endonuclease from rat liver. J. Biol. Chem. 1999, 274:7128-7136.
178. Karahalil B., de Souza-Pinto N.C., Parsons J.L., Elder R.H., Bohr V.A. Compromised incision of oxidative pyrimidines in liver mitochondria of mice deficient in NTH1 and OGG1 glycosylases. J. Biol. Chem. 2003, 36:33701-33707.
179. Stierum R.H., Dianov G.L., Bohr V.A. Single-nucleotide patch base excision repair of uracil in DNA by mitochondrial protein extracts. Nucl. Acids Res. 1999, 27:3712-3719.
180. Pinz K.G., Bogenhagen D.F. Efficient repair of abasic sites in DNA by mitochondrial enzymes. Mol. Cell Biol. 1998, 18:1257-1265.
181. Tell G., Crivellato E., Pines A., Paron I., Pucillo C., Manzini G., Bandiera A., Kekkey M.R., DiLoreto C., Damante G. Mitochondrial localization of APE/Ref-1 in thyroid cells. Mutat. Res. 2001, 485:143-152.
182. Kaguni L.S. DNA polymerase γ. The mitochondrial replicase. Annu. Rev. Biochem. 2004, 73:293-320.
183. Lakshmipathy U., Campbell C. Antisense-mediated decrease in DNA ligase III expression results in reduced mitochondrial DNA integrity. Nucl. Acids Res. 2001, 29:668-676.